List of SBIR/STTR awards granted to Forcyte Biotechnologies | 8 results

Name	Description	SBIR/STTR Award Recipient	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
‌ Forcyte Biotechnologies, Inc. SBIR Phase I Award, August 2018	A SBIR Phase I contract was awarded to Forcyte Biotechnologies in August, 2018 for $224,997.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Forcyte Biotechnologies	National Institutes of Health	SBIR	1R43HD097002-01	Phase I	224,997	August 1, 2018	sbir.gov/node/1571121
‌ Forcyte Biotechnologies, Inc. SBIR Phase II Award, August 2019	A SBIR Phase II contract was awarded to Forcyte Biotechnologies in August, 2019 for $826,810.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Forcyte Biotechnologies	National Institutes of Health	SBIR	2R44TR002350-02	Phase II	826,810	August 6, 2019	sbir.gov/node/1686451
‌ Forcyte Biotechnologies, Inc. SBIR Phase I Award, April 2018	A SBIR Phase I contract was awarded to Forcyte Biotechnologies in April, 2018 for $288,031.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Forcyte Biotechnologies	National Institutes of Health	SBIR	1R43AT009962-01	Phase I	288,031	April 5, 2018	sbir.gov/node/1573229
‌ Forcyte Biotechnologies, Inc. SBIR Phase I Award, January 2018	A SBIR Phase I contract was awarded to Forcyte Biotechnologies in January, 2018 for $224,987.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Forcyte Biotechnologies	National Institutes of Health	SBIR	1R43TR002350-01	Phase I	224,987	January 1, 2018	sbir.gov/node/1565477
‌ Forcyte Biotechnologies, Inc. STTR Phase I Award, September 2021	A STTR Phase I contract was awarded to Forcyte Biotechnologies in September, 2021 for $350,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Forcyte Biotechnologies	National Institutes of Health	STTR	1R41GM146269-01	Phase I	350,000	September 14, 2021	sbir.gov/node/2189223
‌ Forcyte Biotechnologies, Inc. SBIR Phase I Award, July 2021	A SBIR Phase I contract was awarded to Forcyte Biotechnologies in July, 2021 for $352,511.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Forcyte Biotechnologies	National Institutes of Health	SBIR	1R43DK129187-01A1	Phase I	352,511	July 1, 2021	sbir.gov/node/2191611
‌ Forcyte Biotechnologies, Inc. SBIR Phase II Award, September 2019		Forcyte Biotechnologies							forcytebio.com/2019/09/11/forcyte-awarded-phase-2-sbir-by-nih-ncats-to-develop-pseudo-3d-contractile-tissuoid-assay-enabling-study-of-coordinated-cell-contractions-and-tachyphylaxis
‌ Forcyte Biotechnologies, Inc. SBIR Phase I Award, July 2018		Forcyte Biotechnologies							forcytebio.com/2018/07/24/forcyte-awarded-nih-funding-for-a-flecs-based-uterine-contractility-model